Your browser doesn't support javascript.
loading
Improving Clinician Awareness of and Screening for Chagas Disease with an Educational Intervention.
Wheelock, Alyse; Sandhu, Sukhmeet; Reifler, Katherine; Carrion, Malwina; Bourque, Daniel L; Hamer, Davidson H; Hochberg, Natasha S.
Afiliação
  • Wheelock A; Section of Preventive Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.
  • Sandhu S; Section of Infectious Diseases, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.
  • Reifler K; Department of Medicine, Boston Medical Center, Boston, Massachusetts.
  • Carrion M; Section of Infectious Diseases, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.
  • Bourque DL; Boston University Sargent College of Health and Rehabilitation Sciences, Boston, Massachusetts.
  • Hamer DH; Section of Infectious Diseases, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.
  • Hochberg NS; Section of Infectious Diseases, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.
Am J Trop Med Hyg ; 111(2): 380-386, 2024 Aug 07.
Article em En | MEDLINE | ID: mdl-38889732
ABSTRACT
Chagas disease is an underrecognized, chronic, and potentially life-threatening disease caused by the parasite Trypanosoma cruzi. We aimed to improve awareness and screening for Chagas disease among patients from endemic areas using a large safety-net academic hospital system in the United States. We developed an educational intervention consisting of a case-based didactic session presented to physicians, trainees, and other healthcare providers at conferences across different departments. Performance on a knowledge assessment administered before and after the presentation was analyzed with paired Student's t-test for within-subject difference testing. Institutional testing rates for T. cruzi were evaluated for an equal time period (29 months) before and after the start of the intervention. Testing rates were compared by a Welch's unequal variances t-test and by interrupted time series based on multivariate linear regression. Eleven educational sessions were held over the intervention period, and 103 participants completed the pre- and post-presentation surveys. The mean survey scores were 59.2% before the presentation and 96.6% after presentation (P <0.001). Trypanosoma cruzi testing during the postintervention period was significantly higher than testing during the pre-intervention period (171 patients pre-intervention versus 378 patients postintervention [P = 0.015]). Notable increases in testing from the pre-intervention to postintervention periods occurred among midwives (1-68 patients tested) and trainees (57-133 patients tested). Overall, 56/537 (10.4%) nonduplicate T. cruzi commercial screening tests were positive. Testing increased over time, both at an institutional level and within targeted departments. In addition to the educational program, other factors likely influenced expanded testing.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trypanosoma cruzi / Programas de Rastreamento / Doença de Chagas Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Am J Trop Med Hyg Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trypanosoma cruzi / Programas de Rastreamento / Doença de Chagas Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Am J Trop Med Hyg Ano de publicação: 2024 Tipo de documento: Article